Emerging antibody products and Nicotiana manufacturing

References

• De Muynck B, Navarre C, Boutry M. Production of antibodies in plants: status after twenty years. Plant Biotech J 2010; 529 - 563
   PubMed Web of Science ®Google Scholar
• Faye l, Gomord V. Success stories in molecular farming—a brief overview. Plant Biotech J 2010; 8:525 - 528
   PubMed Web of Science ®Google Scholar
• Hiatt AH, Caffertey R, Bowdish K. Production of antibodies in transgenic plants. Nature 1989; 342:76 - 78
   PubMed Web of Science ®Google Scholar
• Ma Jk, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, et al. Generation and assembly of secretory antibodies in plants. Science 1995; 268:716 - 719
   PubMed Web of Science ®Google Scholar
• Mason HS, Lam DMK, Arntzen CJ. Expression of hepatitis B surface antigen in transgenic plants. PNAS 1992; 89:11745 - 11749
   PubMed Web of Science ®Google Scholar
• Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V, Gleba Y. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. PNAS 2006; 103:14701 - 14706
   PubMed Web of Science ®Google Scholar
• Pogue GP, Vojdani F, Palmer KE, Hiatt E, Hume S, Phelps J, et al. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotech J 2010; 8:638 - 654
   PubMed Web of Science ®Google Scholar
• Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol Bioeng 2010; 106:9 - 17
   PubMed Web of Science ®Google Scholar
• Sainsbury F, Lomonossoff GP. Extremely high-level and rapid protein production in plants without the use of viral replication. Plant Physiology 2008; 148:1212 - 1218
   PubMed Web of Science ®Google Scholar
• Vezina LP, Faye L, Lerouge P, D'Aoust MA, Marquet-Blouin E, Burel C, et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotech J 2009; 7:442 - 455
   PubMed Web of Science ®Google Scholar
• Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotech J 2010; 8:564 - 587
   PubMed Web of Science ®Google Scholar
• Schahs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotech J 2007; 5:657 - 663
   PubMed Web of Science ®Google Scholar
• Strasser R, Stadlmann J, Schahs M, Stiegler G, Quendler H, Mach L, et al. Generation of glycoengineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotech J 2008; 6:392 - 402
   PubMed Web of Science ®Google Scholar
• Yamane-Ohnuki N, Satoh M. Production of therapeutic antibodies with controlled fucosylation. mAbs 2009; 1:230 - 236
   PubMed Web of Science ®Google Scholar
• Strasser R, Castilho A, Stadlmann J, Kunert R, Quendler H, Gattinger P, et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol Chem 2009; 284:20479 - 20485
   PubMed Web of Science ®Google Scholar
• Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, Gattinger P, et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010; 285:15923 - 15930
   PubMed Web of Science ®Google Scholar
• Hossler P, Khattak SF, Li ZJ. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 2009; 19:936 - 949
   PubMed Web of Science ®Google Scholar
• Glasier A, Gülmezoglu AM, Schmid GP, Moreno CG, Van Look PF. Sexual and reproductive health: a matter of life and death. Lancet 2006; 368:1595 - 1607
   PubMed Web of Science ®Google Scholar
• Singh S, Darroch JE, Vlassoff M, Nadeau J. Adding it up: the Benefits of Investing in Sexual and Reproductive Health Care 2004; New York UNFPA/Alan Guttmacher Institute
   Google Scholar
• Greene ME, Merrick TW. Poverty Reduction: Does Reproductive Health Matter?. HNP Discussion Paper Series 2005; Washington, DC World Bank
   Google Scholar
• The World Bank's Reproductive Health Action Plan 2010–2015 2010; World Bank
   Google Scholar
• Cates W. Family planning: the essential link to achieving all eight Millennium Development Goals. Contraception 2010; 81:460 - 461
   PubMed Web of Science ®Google Scholar
• PATH and the Coalition Advancing Multipurpose Innovations (CAMI). Saving Lives With Multipurpose Prevention Technologies: Turning Ideas Into Solutions for Sexual and Reproductive Health 2010; Seattle PATH
   Google Scholar
• Morris G, Chindove S, Woodhall S, Wiggins R, Vcelar B, Lacey C. A prospective randomized double blind placebo-controlled phase 1 pharmacokinetic and safety study of a vaginal microbicide gel containing three potent broadly neutralizing monoclonal antibodies (2F5, 2G12, 4E10) (MabGel). Microbicides 2010; Abstract LB1
   Google Scholar
• Rademacher T, Sack M, Arcalis E, Stadlmann J, Balzer S, Altmann F, et al. Recombinant antibody 2G12 produced in maize endosperm efficiently neutralizes HIV-1 and contains predominantly sincle GlcNAc N-glycans. Plant Biotech J 2008; 6:189 - 201
   PubMed Web of Science ®Google Scholar
• Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G, et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. PNAS 105:3727 - 3732
   PubMed Web of Science ®Google Scholar
• Drake PMW, Barbi T, Sexton A, McGowan E, Stadlmann J, Navarre C, et al. Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. FASEB J 2009; 23:3581 - 3589
   Google Scholar
• Sexton A, Harman S, Shattock RJ, Ma JK. Design, expression and characterization of a multivalent, combination HIV microbicide. FASEB J 2009; 23:3590 - 3600
   PubMed Web of Science ®Google Scholar
• O'Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. PNAS 2009; 106:6099 - 6104
   PubMed Web of Science ®Google Scholar
• Matoba N, Husk AS, Barnettt BW, Pickel MM, Arntzen CJ, Montefiori DC, et al. HIV-1 neutralization profile and plant-based recombinant expression of Actinohivin and Env glycan-specific lectin temoid of T-cell mitogenic activity. PLoS One 2010; 5:11143
   Web of Science ®Google Scholar
• Cone RA, Whaley KJ. Monoclonal antibodies for reproductive health: Preventing sexual transmission of disease and pregnancy with topically applied antibodies. Am J Reprod Immunol 1994; 32:114 - 131
   PubMed Web of Science ®Google Scholar
• Castle PE, Whaley KJ, Hoen TE, Moench TR, Cone RA. Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits. Biol Reprod 1997; 56:153 - 159
   PubMed Web of Science ®Google Scholar
• Olmsted SS, Pdgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human ⇑cervical mucus. Biophys J 2001; 81:1930 - 1937
   PubMed Web of Science ®Google Scholar
• Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonett PJ, Corthesy B. Secretory component a new roled in secretory IgA-mediataed immune exclusion in vivo. Immunity 2002; 17:107 - 115
   PubMed Web of Science ®Google Scholar
• Kelley B. Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Prog 2007; 23:995 - 1008
   PubMed Web of Science ®Google Scholar
• Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and metaanalysis. Lancet 2010; 375:1545 - 1555
   PubMed Web of Science ®Google Scholar
• Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25 - 30
   PubMed Web of Science ®Google Scholar
• Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13:371 - 384
   PubMed Web of Science ®Google Scholar
• Vogel AM, McKinlay MJ, Ashton T, Lennon DR, Harding JE, Pinnock R, Graham D, et al. Cost-effectiveness of palivizumab in New Zealand. J Paediatr Child Health 2002; 38:352 - 357
   PubMed Web of Science ®Google Scholar
• Joffe S, Ray GT, Escobar GJ, Black SB, Lieu TA. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics 1999; 104:419 - 427
   PubMed Web of Science ®Google Scholar
• Roeckl-Wiedmann I, Liese JG, Grill E, Fischer B, Carr D, Belohradsky BH. Economic evaluation of possible prevention of RSV-related hospitalizations in premature infants in Germany. Eur J Pediatr 2003; 162:237 - 244
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. The anti-inflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 2007; 204:11 - 15
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008; 26:513 - 533
   PubMed Web of Science ®Google Scholar
• Bayry J, Kazatchkin MD, Kaveri SV. Shortage of human intravenous immunoglobulin—reasons and possible solutions. Nat Clin Pract Neurol 2007; 3:120 - 121
   PubMedGoogle Scholar
• Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody induced autoimmune disease. Immunity 2003; 18:573 - 581
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 2006; 203:789 - 797
   PubMed Web of Science ®Google Scholar
• Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001; 291:484 - 486
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 2005; 310:1510 - 1512
   PubMed Web of Science ®Google Scholar
• Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Identification of a receptor required for the anti-inflammatory activity of IVI. Proc Natl Acad Sci USA 2008; 105:19571 - 19578
   PubMed Web of Science ®Google Scholar
• Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008; 320:373 - 376
   PubMed Web of Science ®Google Scholar
• Wong KT, Allen IV, McQuaid S, McConnell R. An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic Parkinsonism. Clin Neuropathol 1996; 15:22 - 25
   PubMed Web of Science ®Google Scholar
• Kayed R, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300:486 - 489
   PubMed Web of Science ®Google Scholar
• Hartley DM, et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 1999; 19:8876 - 8884
   PubMed Web of Science ®Google Scholar
• Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, et al. Biological markers of amyloid β-related mechanisms in Alzheimer's disease. Exp Neurol 2010; 223:334 - 346
   PubMed Web of Science ®Google Scholar
• Tabira T. Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies. Tohoku J Exp Med 2010; 220:95 - 106
   PubMed Web of Science ®Google Scholar
• D'Aoust MA, Couture MMJ, Charland N, Trepanier S, Landry N, Ors F, Vezina LP. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficicient and safe response to pandemic influenza. Plant Biotech J 2010; 8:607 - 619
   PubMed Web of Science ®Google Scholar
• Bendandi M, Marillonnnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann Oncol 2010; 21:2420 - 2427
   PubMed Web of Science ®Google Scholar
• Lai H, Engle M, Fuchs A, Keller T, Johnson S, Gorlatov S, et al. Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice. PNAS 2010; 107:2419 - 2424
   PubMed Web of Science ®Google Scholar
• Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000; 287:1664 - 1666
   PubMed Web of Science ®Google Scholar
• Pujol M, Ramierez NI, Ayala, Gavilondo JV, Valdes R, Rodriguez M, et al. An integral approach towards a practical application of a plant-made monoclonal in vaccine purification. Vaccine 2005; 23:1833 - 1837
   PubMed Web of Science ®Google Scholar
• McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase 1 clinical study. PNAS 2008; 105:101031 - 101036
   Web of Science ®Google Scholar
• Werner S, Marillonnet S, Hause G, Klimyuk V, Gleba Y. Immunoabsorbent nanoparticles based on a tobamorvirus displaying protein A. PNAS 2006; 103:17678 - 17683
   PubMed Web of Science ®Google Scholar
• Glovokin M, Spitsin S, Andrianov V, Smirnov Y, Xiao Y, Pogrebnyak N, et al. Smallpox subunit vaccine produced in planta confers protection in mice. PNAS 2007; 104:6864 - 6869
   PubMed Web of Science ®Google Scholar
• Brodzik R, Spitsin S, Pogrebnyah K, Banurska K, Portocarrero C, Andryszak K, et al. Generation of plant-derived recombinant DTP subunit vaccine. Vaccine 2009; 27:3730 - 3734
   PubMed Web of Science ®Google Scholar
• Oxfam/Medecins Sans Fronteries. Giving developing countries the best shot: An overview of vaccine access and R&D 2010;
   Google Scholar
• Conrad U, Plagmann I, Malchow S, Sack M, Floss DM, Kruglov AA, et al. ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock. Plant Biotechnol J 2011; 9:22 - 31
   PubMed Web of Science ®Google Scholar
• Grohs BM, Niu Y, Veldhuis L, Trabelsi S, Garabagi F, Hassell JA, et al. Plant-produced Trastuzumab inhibits the growth of HER2 positive cancer cells in vitro. Plant Biotech J 2010; 58:10056 - 10063
   Google Scholar